Chargement en cours...
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectives
The addition of trastuzumab to the treatment of a subset of patients with advanced gastric and gastroesophageal junction cancers showing HER2 positivity has been shown to confer clinical benefit; however, questions remain over the optimal methods for defining and selecting such patients. This review...
Enregistré dans:
| Publié dans: | Onco Targets Ther |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5135398/ https://ncbi.nlm.nih.gov/pubmed/27932891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S100643 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|